AU2016279139B2 - Method for treating or preventing dry eyes - Google Patents

Method for treating or preventing dry eyes Download PDF

Info

Publication number
AU2016279139B2
AU2016279139B2 AU2016279139A AU2016279139A AU2016279139B2 AU 2016279139 B2 AU2016279139 B2 AU 2016279139B2 AU 2016279139 A AU2016279139 A AU 2016279139A AU 2016279139 A AU2016279139 A AU 2016279139A AU 2016279139 B2 AU2016279139 B2 AU 2016279139B2
Authority
AU
Australia
Prior art keywords
compound
formula
dry eye
eyes
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2016279139A
Other languages
English (en)
Other versions
AU2016279139A1 (en
Inventor
Lin-Yea HORNG
Rong-Tsun Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2016279139A1 publication Critical patent/AU2016279139A1/en
Application granted granted Critical
Publication of AU2016279139B2 publication Critical patent/AU2016279139B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU2016279139A 2015-06-16 2016-06-16 Method for treating or preventing dry eyes Active AU2016279139B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562180450P 2015-06-16 2015-06-16
US62/180,450 2015-06-16
PCT/CN2016/000309 WO2016201953A1 (en) 2015-06-16 2016-06-16 Method for treating or preventing dry eyes

Publications (2)

Publication Number Publication Date
AU2016279139A1 AU2016279139A1 (en) 2018-01-04
AU2016279139B2 true AU2016279139B2 (en) 2020-09-10

Family

ID=57544797

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016279139A Active AU2016279139B2 (en) 2015-06-16 2016-06-16 Method for treating or preventing dry eyes

Country Status (9)

Country Link
US (1) US10383885B2 (https=)
EP (1) EP3310361B1 (https=)
JP (1) JP6960399B2 (https=)
KR (1) KR102606948B1 (https=)
CN (1) CN107921053B (https=)
AU (1) AU2016279139B2 (https=)
CA (1) CA2989341C (https=)
TW (1) TWI649083B (https=)
WO (1) WO2016201953A1 (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120164242A1 (en) * 2010-12-27 2012-06-28 Wen-Jen Yu Novel methods for modulating melanin production

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1332726A (zh) * 1998-11-02 2002-01-23 卫福有限公司 吡咯烷化合物及其药物用途
NZ517556A (en) * 1999-09-06 2003-08-29 Ono Pharmaceutical Co N-[o-(p-pivaloyloxybenzenesulphonyl-amino)benzoyl]glycine as preventive and therapeutic agents for eye diseases
CN1257176C (zh) * 2003-10-24 2006-05-24 广州中医药大学热带医学研究所 2，3，5，4＇－四羟基二苯乙烯－2－O－β－D－葡萄糖苷在制备降血脂药物中的应用
US20060292099A1 (en) * 2005-05-25 2006-12-28 Michael Milburn Treatment of eye disorders with sirtuin modulators
US20100160243A1 (en) * 2008-12-24 2010-06-24 National Yang-Ming University Compounds and methods for enhancing erythropoiesis
CN101966193B (zh) * 2010-10-29 2012-05-23 西南交通大学 2,3,5,4’-四羟基二苯乙烯-2-O-β-D-葡萄糖苷在制备治疗抑郁症药物中的应用
AU2013384234A1 (en) * 2013-03-28 2015-10-15 Rong-Tsun Wu Composition and method for inducing EPO-mediated haemoglobin expression and mitochondrial biogenesis in nonhaematopoietic cell
CN103524576A (zh) * 2013-08-12 2014-01-22 天津中医药大学 2,3,5,4′-四羟基二苯乙烯-2-O-β-D-葡萄糖苷的分离纯化工艺

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120164242A1 (en) * 2010-12-27 2012-06-28 Wen-Jen Yu Novel methods for modulating melanin production

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
XIANG KE ET AL, THROMBOSIS RESEARCH, (2013-11-15), vol. 133, no. 2, pages 211-217 *

Also Published As

Publication number Publication date
KR20180019151A (ko) 2018-02-23
EP3310361A1 (en) 2018-04-25
CA2989341C (en) 2021-12-07
JP6960399B2 (ja) 2021-11-05
TW201717965A (zh) 2017-06-01
AU2016279139A1 (en) 2018-01-04
EP3310361A4 (en) 2019-01-23
WO2016201953A1 (en) 2016-12-22
TWI649083B (zh) 2019-02-01
CN107921053A (zh) 2018-04-17
US10383885B2 (en) 2019-08-20
JP2018517776A (ja) 2018-07-05
US20180193369A1 (en) 2018-07-12
CA2989341A1 (en) 2016-12-22
KR102606948B1 (ko) 2023-11-27
CN107921053B (zh) 2020-09-01
EP3310361B1 (en) 2022-05-11

Similar Documents

Publication Publication Date Title
US9925201B2 (en) Compositions and treatment for eye diseases and disorders
Cholkar et al. Topical delivery of aqueous micellar resolvin E1 analog (RX-10045)
AU2009271129A1 (en) Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders
US10835494B2 (en) Liposomes for the treatment of ocular diseases
US10010586B2 (en) Method of treating intraocular tissue pathologies with nerve growth factor
EA035335B1 (ru) Способы лечения офтальмологических расстройств с применением варениклина
Mancini et al. Topical insulin used alone or in combination with drug-depository contact lens for refractory cases of neurotrophic keratopathy
EP3968949A1 (en) Triamcinolone acetonide-loaded liposomes topical ophthalmic formulations for prevention of macular thickening and its associated visual outcomes after lens surgery
AU2016279139B2 (en) Method for treating or preventing dry eyes
US12510536B2 (en) Method for changing condition of eyelid of hairless animal
WO2015068020A2 (en) Immunosuppressive treatments, formulations and methods
AU2013291970B2 (en) Baclofen and acamprosate based therapy of Macular Degeneration disorders
US20250360185A1 (en) Compositions comprising pedf-derived short peptides for the treatment of dry eye diseases
WO2025140240A1 (zh) 一种用于治疗和/或预防角膜损伤的药物组合物和方法
WO2023183603A1 (en) Topical use of terbinafine and similar compounds for inflammatory ocular conditions
Garrigue et al. A comparative study of latanoprost-cationic emulsion (Catioprost) and latanoprost aqueous solution (Xalatan) in preclinical efficacy and safety models
Al-Saedi Formulation and in vitro evaluation of cyclosporine A inserts prepared using HPMC for treating dry eye disease

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)